Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
J Altern Complement Med ; 27(1): 12-23, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32955916

ABSTRACT

Objectives: Acupuncture is an important Traditional Chinese Medicine modality based on the fundamental theory that disease is caused by disruptions in the body's qi. Understanding the use of acupuncture in dermatology is important due to the rising prevalence of complementary and alternative medicine use. A systematic review published in 2015 found that acupuncture improves outcomes in several dermatological diseases. We performed a systematic review of studies that have been done since then to present updated evidence. Methods: A systematic search of MEDLINE, EMBASE, and the Cochrane Central Register was performed. Studies were limited to clinical trials, controlled studies, case reports, comparative studies, and systematic reviews published in the English language. Studies involving moxibustion, electroacupuncture, or blood-letting were excluded. Results: Results showed that acupuncture improves clinical outcomes in uremic pruritus, atopic dermatitis, urticaria, and itch. Acupuncture does not significantly reduce postoperative itch in patients undergoing cesarean section under spinal anesthesia. Conclusions: While there are some promising studies that support the use of acupuncture for skin diseases, additional large-scale, randomized, sham-controlled trials need to be performed to present consistent high-level evidence of acupuncture's role in dermatology.


Subject(s)
Acupuncture Therapy , Skin Diseases/therapy , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult
2.
Dermatitis ; 31(4): 247-258, 2020.
Article in English | MEDLINE | ID: mdl-32209864

ABSTRACT

: The role of Staphylococcus aureus (SA) in the pathogenesis and management in atopic dermatitis is rapidly evolving. The modern understanding of SA in atopic dermatitis now includes an expanded array of virulence factors, the interplay of clonal and temporal shifts in SA populations, and host factors such as filaggrin and natural moisturizing factor. New, emerging therapies that focus on long-term, targeted elimination of SA colonization are currently under investigation (Br J Dermatol 2017;17(1)63-71). Herein, we discuss and review the latest staphylococcal and microbiome-modifying therapies including topical antibiotics, topical natural oil fatty acids, anti-SA vaccines, microbial transplantation, vitamin D supplementation, dupilumab and proposed future investigative directions.


Subject(s)
Dermatitis, Atopic/microbiology , Dermatitis, Atopic/therapy , Dysbiosis/complications , Staphylococcal Infections/complications , Staphylococcal Infections/drug therapy , Staphylococcus aureus , Anti-Bacterial Agents/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Bacterial Vaccines/therapeutic use , Bridged Bicyclo Compounds, Heterocyclic/therapeutic use , Dermatologic Agents/therapeutic use , Diterpenes/therapeutic use , Dysbiosis/therapy , Filaggrin Proteins , Humans , Laurates/therapeutic use , Microbiota , Monoglycerides/therapeutic use , Probiotics/therapeutic use , Skin/microbiology , Surface-Active Agents/therapeutic use , Symptom Flare Up
SELECTION OF CITATIONS
SEARCH DETAIL